| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in MLYS over the last quarter tilts toward selling: insiders offloaded a net 60,776 shares worth roughly $1.6M. In the past 30 days, 0 insiders bought and 2 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 2 insiders sold in the same window, though all of them still hold shares. Classified under Biotechnology (Health Care sector), MLYS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 7.90M | $201.07M | - | |
| Dir | 5.46M | $138.81M | - | |
| CEO | 603.6K | $15.36M | - | |
| Dir | 588.2K | $14.96M | - | |
| Other | 135.0K | $3.43M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Congleton Jon46 | Chief Executive Officer | Sell | 15,730 | $26.83 | $421,979.27 | -2.2% | +4.5% | - | |
| Apr 9, 2026 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 2,170 | $27.38 | $59,414.60 | -2.8% | +11.9% | - | |
| Mar 13, 2026 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 20,406 | $26.61 | $542,973.39 | -6.1% | -8.6% | - | |
| Jan 14, 2026 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 19,076 | $32.66 | $623,114.66 | -14.5% | -20.3% | - | |
| Jan 12, 2026 | Congleton Jon46 | Chief Executive Officer | Sell | 16,236 | $32.62 | $529,639.60 | -1.2% | -19.3% | - | |
| Jan 12, 2026 | Levy Adam Scott | CFO And Secretary | Sell | 10,758 | $32.14 | $345,723.39 | -55.5% | -19.3% | - | |
| Jan 12, 2026 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 8,518 | $32.56 | $277,339.14 | -6.4% | -19.3% | - | |
| Jan 5, 2026 | Rodman David Malcom54 | Chief Medical Officer | Sale+OE | 262,752 | $35.25 | $9,261,028.10 | -51.6% | -20.8% | - | |
| Nov 20, 2025 | Slingsby Brian Taylor48 | Director, 10% Owner | Sell | 1,000,000 | $43.35 | $43,350,000.00 | -11.2% | -33.3% | - | |
| Nov 13, 2025 | Karydas Daphne | Director | Sale+OE | 15,000 | $45.99 | $689,797.08 | -75.4% | -32.8% | - |